The Role of Positron Emission Tomography and Computed Tomographic (PET/CT) Imaging for Radiation Therapy Planning: A Literature Review
Abstract
:1. Introduction
2. Principles of 18F-FDG-PET
3. Role of PET in Radiotherapy Treatment Planning
3.1. Central Nervous System (Brain) Cancers
3.2. Head and Neck Tumours
3.3. Lung Cancer
3.4. Gynaecological Cancers
3.4.1. Cervical Cancer
3.4.2. Endometrial Carcinoma
3.4.3. Ovarian Cancer
3.5. Anal Cancer
Article Title | Authors | Type of Article | Comments |
---|---|---|---|
The Role of Positron Emission Tomography Imaging in Radiotherapy Target Delineation | Menon, et al. 2020 [6] | Review article | CNS, thoracic, gynaecologic, genitourinary, gynaecologic, hematologic |
Use of PET and Other Functional Imaging to Guide Target Delineation in Radiation Oncology | Verma, et al. 2018 [7] | Review article | CNS, thoracic, gynaecologic, genitourinary, gynaecologic, hematologic |
Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 1 | Alongi, et al. 2019 [11] | Expert review | Brain, head and neck and lungs |
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas | Albert, et al. 2016 [15] | Practice Guideline Practice | Brain |
Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients—a report of the PET/RANO group | Galldiks, et al. 2021 [17] | Practice Guideline | Brain |
Role of 18FDG-PET/CT for radiotherapy planning in head and neck cancer | Farre, et al. 2013 [23] | Cross-sectional | Head and neck |
Tumour volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen | Daisne, et al. 2004 [24] | Cross-sectional | Head and neck |
Variation in Radiotherapy Target Volume Definition, Dose to Organs at Risk and Clinical Target Volumes using Anatomic (Computed Tomography) versus Combined Anatomic and Molecular Imaging (Positron Emission Tomography/Computed Tomography): Intensity-modulated Radiotherapy Delivered using a Tomotherapy Hi Art Machine: Final Results of the Vortig ERN Study | Chatterjee, et al. 2012 [25] | Cross-sectional | Head and neck |
Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo–laryngeal squamous cell carcinoma: comparison between pre- and per-treatment studies | Geets, X, et al. 2006 [26] | Cross-sectional | Head and neck |
Combined 18F-FDG-PET/CT Imaging in Radiotherapy Target Delineation for Head-and-Neck Cancer | Guido, et al. 2009 [27] | Cross-sectional | Head and neck |
What is the prognostic impact of FDG PET in locally advanced head and neck squamous cell carcinoma treated with concomitant chemo-radiotherapy? A systematic review and meta-analysis. | Bonomo P, et al. 2018 [28] | Systematic review | Head and neck |
18F-FDG-PET in guided dose-painting with intensity modulated radiotherapy in oropharyngeal tumours: A phase I study (FiGaRO). | Michaelidou A, et al. 2021 [29] | Phase 1 trail | Head and neck |
Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F] FDG-PET/CT external beam radiation treatment planning in lung cancer | Vaz, et al. 2022 [30] | Guideline perspective | Lung |
Positron emission tomography and computed tomographic imaging (PET/CT) for dose planning purposes of thoracic radiation with curative intent in lung cancer patients: A systematic review and meta-analysis. | Hallqvist A, et al. 2017 [31] | Systematic review | Lung |
Prognositc significance of SUVmax on pretreatment 18 F-FDG PET/CT in early-stage non-small cell lung cancer treated with stereotactic body radiotherapy: A meta-analysis | Dong M, et al. 2017 [32] | Meta-analysis | Lung |
NCCN clinical practice guidelines in oncology: cervical cancer version 1 | NCCN 2022 [33] | Practice guideline | Cervix |
[18F] FDG-PET or PET/CT in the evaluation of pelvic and para-aortic lymph nodes in patients with locally advanced cervical cancer: A systematic review of the literature | Adam, et al. 2020 [34] | Systematic review | Cervix |
Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 2 | Fiorentino, et al. 2019 [35] | Expert review | Pancreas, prostate, gynaecological and rectum/anal cancer. |
The role of PET-CT in radiotherapy planning of solid tumours | Jelercic, et al. 2015 [37] | Review article | Lung, head and neck, oesophageal and cervix |
Evidence for the use PET for radiation therapy planning in patients with cervical cancer: a systematic review | Salem, et al. 2011 [39] | Systematic review | Cervix |
The Role of PET Imaging in Gynaecologic Radiation Oncology. | Rao YJ, et al. 2018 [41] | Review | Gynaecological |
Computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography/computer tomography for detection of metastatic lymph nodes in patients with ovarian cancer: A meta-analysis. | Yuan Y, et al. 2012 [44] | Meta-analysis | Ovary |
NCCN clinical practice guidelines in oncology: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, version 5 | NCCN 2022 [46] | Practice guideline | Ovary |
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomized, multicentre study | Hofman, et al. 2020 [47] | RCT, cross over trial | Anal |
Positron emission tomography and computed tomographic (PET/CT) imaging for radiation therapy planning in anal cancer: A systematic review and meta-analysis | Albertsson P, et al. 2018 [49] | Systematic review | Anal |
PET/CT in Radiation Therapy Planning | Specht, et al. 2018 [51] | Review article | Lymphoma |
PET imaging in anal canal cancer: a systematic review and meta-analysis | Mahmud, et al. 2017 [52] | Systematic review | Anal |
3.6. Prostate Cancer
3.7. Others
4. PET/CT Services in Africa
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Chen, H.H.W.; Kuo, M.T. Improving radiotherapy in cancer treatment: Promises and challenges. Oncotarget 2017, 8, 62742–62758. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gupta, T.; Beriwal, S. PET/CT-guided radiation therapy planning: From present to the future. Indian J. Cancer 2010, 47, 126–133. [Google Scholar] [CrossRef] [PubMed]
- Delikgoz Soykut, E.; Ozsahin, E.M.; Yukselen Guney, Y.; Aytac Arslan, S.; Derinalp or, O.; Altundag, M.B.; Ugurluer, G.; Tsoutsou, P.G. The use of PET/CT in radiotherapy planning: The contribution of deformable registration. Front. Oncol. 2013, 3, 33. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Beaton, L.; Bandula, S.; Gaze, M.N.; Sharma, R.A. How rapid advances in imaging will define the future of precision radiation oncology. Br. J. Cancer 2019, 120, 779–790. [Google Scholar] [PubMed] [Green Version]
- Lapa, C.; Nestle, U.; Albert, N.L.; Baues, C.; Beer, A.; Buck, A.; Budach, V.; Bütof, R.; Combs, S.E.; Derlin, T.; et al. The value of PET imaging for radiation therapy. Strahlenther. Onkol. 2021, 197, 1–23. [Google Scholar] [CrossRef] [PubMed]
- Menon, H.; Guo, C.; Verma, V.; Simone, C.B. The Role of Positron Emission Tomography Imaging in Radiotherapy Target Delineation. PET Clin. 2020, 15, 45–53. [Google Scholar] [CrossRef]
- Verma, V.; Choi, J.I.; Sawant, A.; Gullapalli, R.P.; Chen, W.; Alavi, A.; Simone, C.B. Use of PET and Other Functional Imaging to Guide Target Delineation in Radiation Oncology. Semin. Radiat. Oncol. 2018, 28, 171–177. [Google Scholar] [CrossRef]
- Kuo, P.; Chen, Z.; Weldhass, J. FDG-PET-CT for Planning of Radiation Therapy. Appl. Radiol. 2008. Available online: https://appliedradiology.com/articles/fdg-pet-ct-for-planning-of-radiation-therapy (accessed on 14 October 2022). [CrossRef]
- Omami, G.; Tamimi, D.; Branstetter, B.F. Basic principles and applications of 18F-FDG-PET/CT in oral and maxillofacial imaging: A pictorial essay. Imaging Sci. Dent. 2014, 44, 325–332. [Google Scholar] [CrossRef] [Green Version]
- Miele, E.; Spinelli, G.P.; Tomao, F.; Zullo, A.; De Marinis, F.; Pasciuti, G.; Rossi, L.; Zoratto, F.; Tomao, S. Positron Emission Tomography (PET) radiotracers in oncology—Utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC). J. Exp. Clin. Cancer Res. 2008, 27, 52. [Google Scholar] [CrossRef]
- Alongi, P.; Laudicella, R.; Desideri, I.; Chiaravalloti, A.; Borghetti, P.; Quartuccio, N.; Fiore, M.; Evangelista, L.; Marino, L.; Caobelli, F.; et al. Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: Part 1. Crit. Rev. Oncol. 2019, 140, 74–79. [Google Scholar] [CrossRef] [PubMed]
- Schinagl, D.A.X.; Kaanders, J.H.A.M.; Oyen, W.J.G. From anatomical to biological target volumes: The role of PET in radiation treatment planning. Cancer Imaging 2006, 6, S107–S116. [Google Scholar] [CrossRef] [PubMed]
- Ling, C.; Humm, J.; Larson, S.; Amols, H.; Fuks, Z.; Leibel, S.; Koutcher, J.A. Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality. Int. J. Radiat. Oncol. 2000, 47, 551–560. [Google Scholar] [CrossRef] [PubMed]
- Ferlay, J.; Ervik, M.; Colombet, M.; Mery, L.; Piñeros, M.; Znaor, A. Global Cancer Observatory: Cancer Today 2020. Available online: http://gco.iarc.fr/today/home (accessed on 3 September 2022).
- Albert, N.L.; Weller, M.; Suchorska, B.; Galldiks, N.; Soffietti, R.; Kim, M.M.; La Fougere, C.; Pope, W.; Law, I.; Arbizu, J.; et al. Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. Neuro-Oncology 2016, 18, 1199–1208. [Google Scholar] [CrossRef]
- Zhang-Yin, J.T.; Girard, A.; Bertaux, M. What Does PET Imaging Bring to Neuro-Oncology in 2022? A Review. Cancers 2022, 14, 879. [Google Scholar] [CrossRef]
- Galldiks, N.; Niyazi, M.; Grosu, A.L.; Kocher, M.; Langen, K.-J.; Law, I.; Minniti, G.; Kim, M.M.; Tsien, C.; Dhermain, F.; et al. Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients–a report of the PET/RANO group. Neuro-Oncology 2021, 23, 881–893. [Google Scholar] [CrossRef]
- Herholz, K.; Langen, K.J.; Schiepers, C.; Mountz, J.M. Brain Tumors. Brain Imaging Update. Semin. Nucl. Med. 2012, 42, 356–370. [Google Scholar] [CrossRef] [Green Version]
- Soldá, F.; Fersht, N. The Use of PET/CT in Radiotherapy Planning for Brain Tumours. In PET/CT in Brain Disorders; Clinicians’ Guides to Radionuclide Hybrid Imaging; Springer: Cham, Switzerland, 2019; pp. 131–143. [Google Scholar] [CrossRef]
- Verger, A.; Kas, A.; Darcourt, J.; Guedj, E. PET Imaging in Neuro-Oncology: An Update and Overview of a Rapidly Growing Area. Cancers 2022, 14, 1103. [Google Scholar] [CrossRef]
- Kunz, M.; Thon, N.; Eigenbrod, S.; Hartmann, C.; Egensperger, R.; Herms, J.; Geisler, J.; La Fougere, C.; Lutz, J.; Linn, J.; et al. Hot spots in dynamic (18) FET-PET delineate malignant tumour parts within suspected WHO grade II gliomas. Neuro-Oncology 2011, 13, 307–316. [Google Scholar] [CrossRef]
- Lohmann, P.; Werner, J.-M.; Shah, N.J.; Fink, G.R.; Langen, K.-J.; Galldiks, N. Combined Amino Acid Positron Emission Tomography and Advanced Magnetic Resonance Imaging in Glioma Patients. Cancers 2019, 11, e153. [Google Scholar] [CrossRef] [Green Version]
- Farré, N.; Díez, L.; Rojas, J.; de Vega, J.; Latorre-musoll, A.; Fernández, A.; Camacho, V.; Majercakova, K.; Buitrago, P.; Giménez, D.; et al. Role of 18FDG-PET/CT for radiotherapy planning in head and neck cancer. Rep. Pract. Oncol. Radiother. 2013, 18, S252. [Google Scholar] [CrossRef] [Green Version]
- Daisne, J.F.; Duprez, T.; Weynand, B.; Lonneux, M.; Hamoir, M.; Reychler, H.; Grégoire, V. Tumour volume in pharyngolaryngeal squamous cell carcinoma: Comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology 2004, 233, 93–100. [Google Scholar] [CrossRef] [PubMed]
- Chatterjee, S.; Frew, J.; Mott, J.; McCallum, H.; Stevenson, P.; Maxwell, R.; Wilsdon, J.; Kelly, C. Variation in Radiotherapy Target Volume Definition, Dose to Organs at Risk and Clinical Target Volumes using Anatomic (Computed Tomography) versus Combined Anatomic and Molecular Imaging (Positron Emission Tomography/Computed Tomography): Intensity-modulated Radiotherapy Delivered using a Tomotherapy Hi Art Machine: Final Results of the VortigERN Study. Clin. Oncol. 2012, 24, e173–e179. [Google Scholar]
- Geets, X.; Daisne, J.F.; Tomsej, M.; Duprez, T.; Lonneux, M.; Grégoire, V. Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo-laryngeal squamous cell carcinoma: Comparison between pre- and per-treatment studies. Radiother. Oncol. 2006, 78, 291–297. [Google Scholar] [CrossRef] [PubMed]
- Guido, A.; Fuccio, L.; Rombi, B.; Castellucci, P.; Cecconi, A.; Bunkheila, F.; Fuccio, C.; Spezi, E.; Angelini, A.L.; Barbieri, E. Combined 18F-FDG-PET/CT Imaging in Radiotherapy Target Delineation for Head-and-Neck Cancer. Int. J. Radiat. Oncol. 2009, 73, 759–763. [Google Scholar] [CrossRef]
- Bonomo, P.; Merlotti, A.; Olmetto, E.; Bianchi, A.; Desideri, I.; Bacigalupo, A.; Franco, P.; Franzese, C.; Orlandi, E.; Livi, L.; et al. What is the prognostic impact of FDG PET in locally advanced head and neck squamous cell carcinoma treated with concomitant chemo-radiotherapy? A systematic review and meta-analysis. Eur. J. Pediatr. 2018, 45, 2122–2138. [Google Scholar] [CrossRef] [Green Version]
- Michaelidou, A.; Adjogatse, D.; Suh, Y.; Pike, L.; Thomas, C.; Woodley, O.; Rackely, T.; Palaniappan, N.; Jayaprakasam, V.; Sanchez-Nieto, B.; et al. 18F-FDG-PET in guided dose-painting with intensity modulated radiotherapy in oropharyngeal tumours: A phase I study (FiGaRO). Radiother. Oncol. 2021, 155, 261–268. [Google Scholar] [CrossRef]
- Vaz, S.C.; Adam, J.A.; Bolton, R.C.D.; Vera, P.; van Elmpt, W.; Herrmann, K.; Hicks, R.J.; Lievens, Y.; Santos, A.; Schöder, H.; et al. Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F] FDG-PET/CT external beam radiation treatment planning in lung cancer. Radiother. Oncol. 2022, 168, 37–39. [Google Scholar] [CrossRef]
- Hallqvist, A.; Alverbratt, C.; Strandell, A.; Samuelsson, O.; Björkander, E.; Liljegren, A.; Albertsson, P. Positron emission tomography and computed tomographic imaging (PET/CT) for dose planning purposes of thoracic radiation with curative intent in lung cancer patients: A systematic review and meta-analysis. Radiother. Oncol. 2017, 123, 71–77. [Google Scholar] [CrossRef] [Green Version]
- Dong, M.; Liu, J.; Sun, X.; ** countries. J. Nucl. Med. 2011, 52 (Suppl. S2), 16S–23S. [Google Scholar] [CrossRef]
- Lee, D.S.; Lee, Y.-S.; Lee, J.S.; Suh, M.S. Promotion of nuclear medicine-related sciences in develo** countries. Nucl. Med. Mol. Imaging 2019, 53, 73–82. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Mallum, A.; Mkhize, T.; Akudugu, J.M.; Ngwa, W.; Vorster, M. The Role of Positron Emission Tomography and Computed Tomographic (PET/CT) Imaging for Radiation Therapy Planning: A Literature Review. Diagnostics 2023, 13, 53. https://doi.org/10.3390/diagnostics13010053
Mallum A, Mkhize T, Akudugu JM, Ngwa W, Vorster M. The Role of Positron Emission Tomography and Computed Tomographic (PET/CT) Imaging for Radiation Therapy Planning: A Literature Review. Diagnostics. 2023; 13(1):53. https://doi.org/10.3390/diagnostics13010053
Chicago/Turabian StyleMallum, Abba, Thokozani Mkhize, John M. Akudugu, Wilfred Ngwa, and Mariza Vorster. 2023. "The Role of Positron Emission Tomography and Computed Tomographic (PET/CT) Imaging for Radiation Therapy Planning: A Literature Review" Diagnostics 13, no. 1: 53. https://doi.org/10.3390/diagnostics13010053